Autoantibodies in neurodegenerative diseases: Antigen-specific frequencies and intrathecal analysis

Neurobiology of Aging

Volumn 19, Issue 3, 1998, Pages 205-216

  Terryberry, J W ^a   Thor, G ^a   Peter, J B ^a  

^a Specialty Laboratories   (United States)

Author keywords

Alzheimer disease; Amyotrophic lateral sclerosis; Autoantibodies; Multiple sclerosis; Neurofilament; Neuropathy; Parkinson disease; Tubulin

Indexed keywords

AMYLOID BETA PROTEIN; AUTOANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN BASIC PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN S 100; PROTEOHEPARAN SULFATE; TAU PROTEIN; TUBULIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGEN SPECIFICITY; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME IMMUNOASSAY; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; MULTIINFARCT DEMENTIA; MULTIPLE SCLEROSIS; NEUROFILAMENT; OPTIC NERVE DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; SERUM;

ANTIBODY SPECIFICITY; ANTIGENS; AUTOANTIBODIES; HIPPOCAMPUS; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES;

EID: 0031825978     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00049-9     Document Type: Article

References (140)

1. Ahlskog, J. E.; Petersen, R. C.; Waring, S. C., et al. Guamanian neurodegenerative disease: Are diabetes mellitus and altered humoral immunity clues to pathogenesis? Neurology 48:1356-1362; 1997.
2. Akiyama, H. Inflammatory response in Alzheimer's disease. Tohuku J. Exp. Med. 174:295-303; 1994.
3. Akiyama, H.; Nishimura, T.; Kondo, H., et al. Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis. Brain Res. 639:171-174; 1994.
4. Amara, A.; Constans, J.; Chaugier, C., et al. Autoantibodies to malondialdehyde-modified epitope in connective tissue disease and vasculitides. Clin. Exp. Immunol. 101:233-238; 1995.
5. Antonaci, S.; Garofalo, A. R.; Chicco, C., et al. Senile dementia, Alzheimer type: A distinct entity in immunosenescence? J. Clin. Lab. Anal. 4:16-21; 1990.
6. Annunziata, P.; Maimone, D.; Guazzi, G. C. Association of polyclonal anti-GMl IgM and anti-neurofilament antibodies with CSF oligoclonal bands in a young patient with amyotrophic lateral sclerosis. Acta Neurol. Scand. 92:387-393; 1995.
7. Apostolski, S.; Nikolic, J.; Bugarski-Prokoplijevic, C., et al. Serum and CSF immunological findings in ALS. Acta Neurol. Scand. 83:96-98; 1991.
8. Armstrong, R. A.; Wood, L.; Myers, D.; Smith C. U. M. The use of multivariate methods in the identification of subtypes of Alzheimer's disease: A comparison of principle components and cluster analysis. Dementia 7:215-220; 1996.
9. Bahmanyer, S.; Liem, R. K. H.; Griffin, J. W.; Gajdusek, D. C. Characterization of antineurofilament autoantibodies in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 43:369-375; 1984.
10. Bahmanyer, S.; Moreau-Dubois, M.-C.; Brown, P., et al. Serum antibodies to neurofilament antigens in patients with neurological and other diseases, and in healthy controls. J. Neuroimmunol. 5:191-196; 1983.
11. Banati, R. B.; Gehrmann, J.; Kellner, M.; Holsboer, F. Antibodies against microglia/brain macrophages in the cerebrospinal fluid of a patient with acute amyotrophic lateral sclerosis and presenile dementia. Clin. Neuropathol. 14:197-200; 1995.
12. Barclay, K. B.; Haines, D. M. Immunohistochemical evidence for immunoglobulin and complement deposition in spinal cord lesions in degenerative myelopathy in German shephard dogs. Can. J. Vet. Res. 58:20-24; 1994.
13. Braxton, D. B.; Williams, M.; Kamali, D., et al. Specificity of human anti-neurofilament autoantibodies. J. Neuroimmunol. 21:193-203; 1989.
14. Brown, R. H.; Johnson, D.; Ogonowski, M.; Weiner, H. L. Antineural antibodies in the serum of patients with amyotrophic lateral sclerosis. Neurology 37:152-157; 1987.
15. Chapman, J.; Alroy, G.; Weiss, Z., et al. Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats. Neuroscience 40:297-305; 1991.
16. Chapman, J.; Bachar, O.; Korczyn, A., et al. Alzheimer's disease antibodies bind specifically to neurofilament protein in Torpedo cholinergic neurons. J. Neurosci. 9:2710-2717; 1989.
17. Connolly, A. M.; Pestronk, A.; Trotter, J. L., et al. High titer selective serum anti-β tubulin antibodies in chronic inflammatory demyelinating polyneuropathy. Neurology 43:557-562; 1993.
18. Connolly, A. M.; Pestronk, A.; Mehta, S., et al. Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of -tubulin: Clinical association with slowly progressive demyelinating polyneuropathy. Neurology 48:243-248; 1997.
19. Corbo, M.; Hays, A. P. Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J. Neuropathol. Exp. Neurol. 51:531-537; 1992.
20. Cullum, N. A.; Coleman, J. W.; Casson, I. F.; McLean, W. G. Antibodies to tubulin and microtubule-associated proteins: A study in diabetes mellitus, systemic lupus erythematosus, and rheumatoid arthritis. Mol. Chem. Neuropathol. 15:159-172; 1991.
21. Dahlstrom, A.; McRae, A.; Polinsky, R., et al. Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia. Mol. Neurobiol. 9:41-54; 1994.
22. Dahlstrom, A.; Wigander, A.; Lundmark, K., et al. Investigations on autoantibodies in Alzheimer's and Parkinson's diseases using defined neuronal cultures. J. Neural. Transm. 29:195-206; 1990.
23. Dehaut, F.; Haddad, K.; Alhayek, G.; Pouplard-Barthelaix, A. Autoantibody against H-and M-subunits of neurofilaments are induced by PC 12 cell grafts or lesions into different sites of rat brain. Neurosci. Lett. 165:59-62; 1994.
24. De La Monte, S. M.; Wands, J. R. Diagnostic utility of quantitating neurofilament immunoreactive Alzheimer's disease lesions. J. Histochem. Cytochem. 42:1625-1634; 1994.
25. Denburg, J. A.; Denburg, S. D.; Carbotte, R. M., et al. Nervous system lupus: Pathogenesis and rationale for therapy. Scand. J. Rheumatol. 24:263-273; 1995.
26. Desai, A.; Ravi, V.; Guru, S. C., et al. Detection of antibodies to neural antigens in the CSF of Japanese encephalitis patients and correlation of findings with clinical outcome. J. Neurol. Sci. 122: 109-116; 1994.
27. de Waegh, S. M.; Lee, V. M.-Y.; Brady, S. T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451-463; 1992.
28. DiPatre, P. L.; Belman, B. B. Microglial cell activation in aging and Alzheimer disease: Partial linkage with neurofibrillary tangle burden in the hippocampus. J. Neuropathol. Exp. Neurol. 56:143-149; 1997.
29. Doroudchi, M. M.; Durham, H. D. Activation of protein kinase C induces neurofilament fragmentation, hyperphosphorylation of perikaryal neurofilaments and proximal dendritic swellings in cultured motor neurons. J. Neuropathol. Exp. Neurol. 55:246-256; 1996.
30. Eikelenboom, P.; Stam, F. C. Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study. Acta Neuropathol. 57:239-242; 1982.
31. Eikelenboom, P.; Rozemuller, J. M.; Kraal, G., et al. Cerebral amyloid plaques in Alzhemer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch. B. 60:329-336; 1991.
32. Eisen, A.; Caine, D. Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: Phylogenetic disorders of the human neocortex sharing many charcteristics. Can. J. Neurol. Sci. 19:117-120; 1992.
33. Elizan, T. S.; Casals, J.; Yahr, M. D. Antineurofilament antibodies in postencephalitic and idiopathic Parkinson's disease. J. Neurol. Sci. 59:341-734; 1983.
34. Evans, H. L. Markers of neurotoxicity: From behaviour to autoantibodies against brain proteins. Clin. Chem. 41:1874-1881; 1995.
35. Fang, Q.; Kannapell, C. C.; Fu, S. M., et al. VH and VL gene usage by anti-β amyloid autoantibodies in Alzheimer's disease: Detection of highly mutated V regions in both heavy and light chains. Clin. Immunol. Immunopathol. 75:159-167; 1995.
36. Fillit, H. M.; Kemeny, E.; Luine, V., et al. Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type. J. Gerontol. 42:180-184; 1987.
37. Finch, C. E.; Marchalonis, J. J. Evolutionary perspectives on amyloid and inflammatory features of Alzheimer disease. Neurobiol. Aging 17:809-815; 1996.
38. Fiszer, U.; Mix, E.; Fredrikson, S., et al. Gamma delta+ T cells are increased in patients with Parkinson's disease. J. Neurol. Sci. 121:39-45; 1994.
39. Foley, P.; Bradford, H. F.; Docherty, M., et al. Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease. J. Neurol. 235:466-471; 1988.
40. Forster, M. J.; Lal, H. Animal models of age-related dementia; neurobehavioural dysfunctions in autoimmune mice. Brain Res. Bull. 25:503-516; 1990.
41. Fountain, N. B.; Eberhard, D. A. Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Neurology 46:190-197; 1996.
42. Frecker, M. F.; Pryse-Phillips, W. E. M.; Strong, H. R. Immunological associations in familial and non-familial Alzheimer patients and their families. Can. J. Neurol. Sci. 21:112-119; 1994.
43. Frolich, L.; Kornhuber, J.; Ihl, R., et al. Integrity of blood-CSF barrier in dementia of the Alzheimer type: CSF/serum ratios of albumin and IgG. Eur. Arch. Psychiatry Clin. Neurosci. 240:363-366; 1991.
44. Fudenberg, H. H.; Singh, V. K. Alzheimer's syndrome: Prognosis and subsets with different etiology, and preliminary effects of immunotherapy. Drug Dev. Res. 15:165-174; 1988.
45. Galbraith, G. M. P.; Emerson, D.; Fudenberg, H. H., et al. Antibodies to neurofilament protein in retinitis pigmentosa. J. Clin. Invest. 78:865-869; 1986.
46. Gaskin, F.; Finley, J.; Fang, Q., et al. Human antibodies reactive with β-amyloid protein in Alzheimer's disease. J. Exp. Med. 177:1181-1186; 1993.
47. Gaskin, F.; Kingsley, B. S.; Fu, S. M. Autoantibodies to neurofibrillary tangles and brain tissue in Alzheimer's disease. J. Exp. Med. 165:245-250; 1987.
48. Gehrmann, J.; Banati, R. B.; Cuzner, M. L., et al. Amyloid precurssor protein (APP) expression in multiple sclerosis lesions. Glia 15:141-151; 1995.
49. Geldmacher, D. S.; Whitehouse, P. J. Evaluation of dementia. N. Engl. J. Med. 335:330-336; 1996.
50. Greiner, A.; Schmaußer, B.; Petzhold, K., et al. Neuronal targets of serum and cerebrospinal fluid autoantibodies in amyotrophic lateral sclerosis. Acta Neuropathol. 91:67-71; 1996.
51. Hartwig, M. Immune ageing and Alzheimer's disease. NeuroReport 6:1274-1276; 1995.
52. Heinonen, O.; Syrjanen, S.; Soininen, H., et al. Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome. Neurosci. Lett. 149:67-70; 1993.
53. Hempen, B.; Brion, J.-P. Reduction of acetylated α-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:964-972; 1996.
54. Ho, G. H.; Smirnova, I. V.; Akaaboune, M., et al. Serine proteases and their serpin inhibitors in Alzheimer disease. Biomed. Pharmacother. 48:296-304; 1994.
55. Huang, D.; Martin, M.; Hu, D., et al. Binding of IgG to amyloid βA4 peptide via the heavy-chain hinge region with preservation of antigen binding. J. Neuroimmunol. 48:199-204; 1993.
56. Huberman, M.; Sredni, B.; Stern, L., et al. IL-2 and IL-6 secretion in dementia; correlation with type and severity of disease. J. Neurol. Sci. 130:161-164; 1995.
57. Ikeda, K.; Akiyama, H.; Kondo, H., et al. Thorn-shaped astrocytes: Possibly secondarily induced T-positive glial fibrillary tangles. Acta Neuropathol. 90:620-625; 1995.
58. Ikeda, T.; Yamamoto, K.; Takahashi, K.; Yamada, M. Immune system-associated antigens on the surface of peripheral blood lymphocytes in patients with Alzheimer's disease. Acta Psychiatr. Scand. 83:444-448; 1991.
59. Itagaki, S.; Akiyama, H.; Saito, H.; McGeer, P. L. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease. Brain Res. 645:78-84; 1994.
60. Jankovic, B. D.; Djordjijevic, D. Differential appearence of autoantibodies to human brain S100 protein, neuron specific enolase and myelin basic protein in psychiatric patients. Int. J. Neurosci. 60:119-127; 1991.
61. Johnston, K. M.; Connelly, J. A.; VanDerKooy, D. Inhibition of axonal transport in vivo by a tubulin-specific antibody. Brain Res. 385:38-45; 1986.
62. Kamiya, M.; Miyakawa, M.; Ueda, G., et al. A monoclonal thymocytotoxic autoantibody from autoimmune disease-prone New Zealand Black mouse recognizes β-tubulin in neural tissue. Neurosci. Res. 16:293-299; 1993.
63. Karcher, D.; Soler-Federsppiel, B. S.; Lowenthal, F. D., et al. Anti-neurofilament antibodies in blood of patients with neurological diseases. Acta Neuropathol. 72:82-85; 1986.
64. Kay, M. M. B.; Wyant, T.; Goodman, J. Autoantibodies to band 3 during aging and disease, and aging interventions. Ann. N. Y. Acad. Sci. 719:419-447; 1994.
65. Kingsley, B. S.; Gaskin, F.; Fu, S. M. Human antibodies to neurofibrillary tangles and astrocytes in Alzheimer's disease. J. Neuroimmunol. 19:89-99; 1988.
66. Kornguth, S. E.; Kalinke, T.; Grunwald, G. B., et al. Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res. 46:2588-2595; 1986.
67. Kumar, M.; Cohen, D.; Eisdorfer, C. Serum IgG brain-reactive antibodies in Alzheimer's disease and Down's syndrome. Alzheimer Dis. Assoc. Disord. 2:50-55; 1988.
68. Kurki, P.; Helve, T.; Dahl, D.; Vitanen, I. Neurofilament antibodies in systemic lupus erythematosus. J. Rheumatol. 13:69-73; 1986.
69. Laemmli, U. K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685; 1970.
70. Lopez, O. L.; Rabin, B. S.; Huff, F. J., et al. Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in non-demented control subjects. Stroke 23:1078-1083; 1992.
71. Manfredini, E.; Nobile-Orazio, E.; Allaria, S.; Scarlato, G. Anti-α-and β-tubulin IgM in dysimmune neuropathies. J. Neurol. Sci. 133:79-84; 1995.
72. Mann, D. M., Davies, J. S.; Hawkes, J.; Yates, P. O. Immunohistochemical staining of senile plaques. Neuropathol. Appl. Neurobiol. 8:55-61; 1982.
73. Marx, A.; Kirchner, T.; Greiner, A., et al. Myasthenia gravis-associated thymic epithelial tumors express neurofilaments and are associated with antiaxonal autoimmunity. Ann. N. Y. Acad. Sci. 681:107-109; 1993.
74. Matsiota, P.; Blancher, A.; Doyon, B., et al. Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann. Inst. Pasteur./Immunol. 139:99-108; 1988.
75. Mattila, K. M.; Pirttila, T.; Blennow, K., et al. Altered blood-brain barrier function in Alzheimer's disease? Acta Neurol. Scand. 89:192-198; 1994.
76. McCrae-Degueurce, A.; Booj, S.; Haglid, K., et al. Antibodies in cerebrospinal fluid of some Alzheimer's disease patients recognize cholinergic neurons in the rat central nervous system. Proc. Natl. Acad. Sci. USA 84:9214-9218; 1987.
77. McGeer, P. L.; Akiyama, H.; Itagaki, S.; McGeer, E. G. Immune system responses in Alzheimer's disease. Can. J. Neurol. Sci. 16:516-527; 1989.
78. McGeer, P. L.; Klegeris, A.; Walker, D. G., et al. Pathological proteins in senile plaques. Tohoku J. Exp. Med. 174:269-277; 1994.
79. McGeer, P. L.; McGeer, E. G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:195-218; 1995.
80. McQuarrie, I. G.; Brady, S. T.; Lasek, R. J. Retardation in the slow axonal transport of cytoskeletal elements during maturation and aging. Neurobiol. Aging 10:359-365; 1989.
81. McRae, A.; Dahlstrom, A.; Polinsky, R.; Ling, E. A. Cerebrospinal fluid microglial antibodies: Potential diagnostic markers for immune mechanisms in Alzheimer's disease. Behav. Brain Res. 57:225-234; 1993.
82. McRae, A.; Ling, E. A.; Polinsky, R., et al. Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system. Neuroscience 441:739-527; 1991.
83. Mecocci, P.; Parnetti, L.; Donato, R., et al. Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias. Brain Behav. Immun. 6:282-292; 1992.
84. Miyasake, H.; Okabe, S.; Ishiguro, K., et al. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II. J. Biol. Chem. 268:22695-22670; 1993.
85. Monning, U.; Schreiter-Gasser, U.; Hilbich, C., et al. Alzheimer amyloid β/A4 protein reactive antibodies in human sera and CSF. In: Iqbal, K.; McLachlan, D. R. C.; Winblad, B.; Wisniewski, H. M., eds., Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. New York: John Wiley and Sons; 1991:557-563.
86. Nease, Jr., R. F.; Owens, D. K.; Sox, Jr., H. C. Threshold analysis using diagnostic tests with multiple results. Med. Decis. Making. 9:91-103; 1989.
87. Osterland, C. K.; St. Louis, E. A. Immune reactivity in aging-autologous mixed lymphocyte responses. Gerontology 38:301-307; 1992.
88. Penfold, P. L.; Provis, J. M.; Furby, J. H., et al. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 228:270-274; 1990.
89. Perry, V. H.; Matyszak, M. K.; Fearn, S. Altered antigen expression of microglia in aged rodent CNS. Glia 7:60-67; 1993.
90. Peter, J. B. Use and interpretation of laboratory tests in neurology. Santa Monica: Specialty Laboratories; 1997.
91. Pouplard, A.; Emile, J. New immunological findings in senile dementia: Pituitary autoantibodies as a marker for Alzheimer's disease. Interdiscipl. Topic. Gerontol. 19:62-71; 1985.
92. Powers, J. M.; Schaepfer, W. W.; Willingham, M. C.; Hall, B. J. An immunoperoxidase study of senile cerebral amyloidosis with pathogenic considerations. J. Neuropathol. Exp. Neurol. 40:592-612; 1981.
93. Reiber, H. External quality assessment in clinical neurochemistry: Survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients. Clin. Chem. 41:256-63; 1995.
94. Robbins, M. L.; Kornguth, S. E.; Bell, C. L., et al. Antineurofilament antibody evaluation in neuropsychiatrie systemic lupus erythematosus. Arthritis Rheum. 31:623-631; 1988.
95. Rogers, J.; Webster, S.; Lue, L.-F., et al. Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17:681-686; 1996.
96. Roussel, B.; Vialettes, B.; Bernier-Valentin, F., et al. Anti-tubulin antibodies in recent onset type 1 (insulin-dependent) diabetes mellitus: Comparison with islet cell antibodies. Diabetologia 27:427-432; 1984.
97. Sakic, B.; Szechtman, H.; Denburg, J. A. Neurobehavioural alterations in autoimmune mice. Neurosci. Biobehav. Rev. 21:327-340; 1997.
98. Sadiq, S. A.; Thomas, F. P.; Kilidireas, K., et al. The spectrum of neurologic disease associated with anti-GMl antibodies. Neurology 40:1067-1072; 1990.
99. Sanyal, T.; Ghosh, D. K.; Sarkar, D. Identification of immune complex antigens in sera of Indian Kala-azar patients. Ind. J. Exp. Biol. 29:411-415; 1991.
100. Schipper, H. M. Astrocytes, brain aging and neurodegeneration. Neurobiol. Aging 17:467-480; 1996.
101. Schmidt, M. L.; Carden, M. T.; Lee, V. M.-Y.; Trojanowski, J. Q. Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with amyotrophic lateral sclerosis. Lab. Invest. 56:282-294; 1987.
102. Schott, K.; Wormstall, H.; Dietreich, M., et al. Autoantibody reactivity in serum of patients with Alzheimer's disease and other age-related dementias. Psychiatry Res. 59:251-254; 1996.
103. Shalit, F.; Sredni, B.; Brodie, G., et al. T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin. Immunol. Immunopathol. 75:246-250; 1995.
104. Sherman, G. F.; Galburda, A. M.; Behan, P. O.; Rosen, G. D. Neuroanatomical anomolies in autoimmune mice. Acta Neuropathol. 74:239-242; 1987.
105. Shoenfeld, Y.; Isenberg, D. A.; Avrameas, S., eds. Natural autoantibodies: Their physiological role and regulatory significance. Boca Raton, FL: CRC Press; 1993:15-40.
106. Singh, V. K. Studies of neuroimmune markers in Alzheimer's disease. Mol. Neurobiol. 9:73-181; 1994.
107. Singh, V. K. Neuroautoimmunity. Pathogenic implications for Alzheimer's disease. Gerontology 43:79-94; 1997.
108. Singh, V. K.; Fudenberg, H. H. Detection of brain autoantibodies in the serum of patients with Alzheimer's disease but not Down's syndrome. Immunol. Lett. 12:277-280; 1986.
109. Singh, V. K.; Fudenberg, H. H.; Brown, F. R. Immunologic dysfunction: Simultaneous study of Alzheimer's and older Down's patients. Mech. Ageing Dev. 37:257-264; 1987.
110. Skias, D.; Bania, M.; Reder, A. T., et al. Senile dementia of the Alzheimer's type (SDAT): Reduced T8+ cell-mediated suppressor activity. Neurology 35:1635-1638; 1985.
111. Smith, R. G.; Appel, S. H. Calcium channel autoantibodies in amyotrophic lateral sclerosis. In: Peter, J.B.; Shoenfeld, Y., eds., Autoantibodies. Elsevier Science, B.V.: Amsterdam; 1996:148-152.
112. Snow, A. D.; Mar, H.; Nochlin, D., et al. Early accumulation of heparan sulfate in neurons and the β-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137:1253-1270; 1990.
113. Soininen, H.; Heinonen, O.; Hallikainen, M., et al. Circulating immune complexes in sera from patients with Alzheimer's disease and subjects with age-associated memory impairment. J. Neural. Transm. 6:179-188; 1993.
114. Sotelo, J.; Gibbs, C. J.; Gajdusek, D. C. Autoantibodies against neurofilaments in patients with Kuru and Creutzfeldt-Jakob disease. Science 210:190-193; 1980.
115. Soussan, L.; Tchernakov, K.; Bachar-Lavi, O., et al. Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease. Mol. Neurobiol. 9:83-91; 1994.
116. Stevens, A.; Weller, M.; Wietholer, H. A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 56:361-364; 1993.
117. Sugiura, M.; Yokoi, Y.; Maruyama, S., et al. Detection of anticerebral autoantibodies in schizophrenia and Alzheimer's disease. J. Clin. Lab. Immunol. 28:1-3; 1989.
118. Tanaka, J.; Murakoshi, K.; Masatoshi, M., et al. A high level of anti-GFAP autoantibody in the serum of patients with Alzheimer's disease. Biomed. Res. 9:209-216; 1988.
119. Tanaka, J.; Nakamura, K.; Takeda, M., et al. Enzyme-linked immunosorbent assay for human autoantibody to glial fibrillary acidic protein: Higher titer of the antibody is detected in serum of patients with Alzheimer's disease. Acta Neurol. Scand. 80:554-560; 1989.
120. Terryberry, J.; Sutjita, M.; Shoenfeld, Y., et al. Myelin- and microbe-specific antibodies in Guillain-Barre syndrome. J. Clin. Lab. Anal. 9:308-319; 1995.
121. Toh, B. H.; Gibbs, C. J.; Gajdusek, D. C., et al. The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with Kuru, Creutzfeldt-Jakob disease and other neurologic diseases. Proc. Natl. Acad. Sci. USA 82:3485-3489; 1985.
122. Tomimoto, H.; Akiguchi, I.; Suenga, T., et al. Alterations of the blood-brain barrier and glial cells in white matter lesions in cerebrovascular and Alzheimer disease patients. Stroke 27:2069-2074; 1996.
123. Torack, R. M. T-lymphocyte function in Alzheimer's disease. Neurosci. Lett. 71:365-9; 1986.
124. Tornqvist, E.; Liu, L.; Aldskogius, H., et al. Complement and clusterin in the injured nervous system. Neurobiol. Aging 17:695-705; 1996.
125. Tourtellotte, W. W.; Staugaitis, S. M.; Walsh, M. J., et al. The basis of intra-blood-brain-barrier IgG synthesis. Ann. Neurol. 17:21-27; 1985.
126. Towbin, H.; Staehelin, T.; Gordon, D. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4353; 1979.
127. Uvestad, E.; Williams, K.; Matre, R., et al. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J. Neuropathol. Exp. Neurol. 53:27-36; 1994.
128. Walker, D. G.; Yasuhara, O.; Patston, P. A., et al. Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease. Brain Res. 675:75-82; 1995.
129. Warren, K. G.; Catz, I. Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission. J. Neurol. Sci. 88:185-194; 1988.
130. Warren, K. G.; Catz, I. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid. J. Neurol. Sci. 121:66-73; 1994.
131. Webster, S.; Bradt, B.; Rogers, J.; Cooper, N. Aggregation state-dependent activation of the classical complement pathway by the amyloid peptide. J. Neurochem. 69:388-398; 1997.
132. Westarp, M. E.; Fuchs, D.; Bartmann, P., et al. Amyotrophic lateral sclerosis: an enigmatic disease with B-cellular and anti-retroviral immune responses. Eur. J. Med. 2:327-332; 1993.
133. Wucherpfennig, K. W. Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition. Clin. Immunol. Immunopathol. 72:293-306; 1994.
134. Wurster, U.; Haas, J. Passage of i.v. immunoglobulin and interaction with the CNS. J. Neurol. Neurosurg. Psychiatry 57(Suppl.):21-25; 1994.
135. Compston, D. A. S.; Scolding, N. J. Immune-mediated oligodendrocyte injury. Ann. N. Y. Acad. Sci. 633:196-204; 1991.
136. Laywell, E. D.; Steindler, D. A. Boundaries and wounds, glia and glycoconjugates: Cellular and molecular analyses of developmental partitions and adult brain lesions. Ann. N. Y. Acad. Sci. 633:122-141; 1991.
137. Spencer, N. F. L.; Poynter, M. E.; Hennebold, J. D., et al. Does DHEAS restore immune competence in aged animals through its capacity to function as a natural modulator of peroxisome activities? Ann. N. Y. Acad. Sci. 774:200-216; 1995.
138. Peress, N. S. Fielt, H.B.; Perillo, E., et al. Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. J. Neuroimmunol. 48:71-79; 1993.
139. Perlmutter, L. S.; Scott, S. A.; Barron, E.; and Chui, H. C. MHC class-II positive microglia in human brain: Association with Alzheimer lesions. J. Neurosci. Res. 33:549-558; 1992.
140. Styren, S. D.; Civin, W. H.; and Rogers, J. Molecular, cellular and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp. Neurol. 110:93-104; 1990.